XML 26 R15.htm IDEA: XBRL DOCUMENT v3.22.2
Commitments and Contingencies (Tables)
9 Months Ended
Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Schedule of exercisable share purchase warrants outstanding
           
      Weighted
      Average
   Number of  Exercise Price
   Shares  ($)
Balance, September 30, 2020    500,000    3.88 
Granted    60,000    12.00 
Exercised    (350,000)   4.19 
Balance, September 30, 2021    210,000    5.69 
Forfeited    (50,000)   12.00 
Balance, June 30, 2022    160,000    3.72 
Schedule of share purchase warrants outstanding
        
Number  Exercise Price  Expiry Date
150,000  $3.17   May 6, 2024
10,000  $12.00   April 21, 2026
160,000        
Schedule of outstanding stock purchase options
                     
      Weighted      
      Average  Weighted Average  Aggregate
   Number of  Exercise Price  Grant Date Fair Value  intrinsic value
   Shares  ($)  ($)  ($)
Outstanding, September 30, 2020    10,076,266    3.48         14,982,581 
Granted    2,732,000    12.55    9.32      
Forfeited    (55,834)   3.04    2.43      
Exercised    (1,421,529)   2.89    2.43    24,446,305 
Outstanding, September 30, 2021    11,330,903    5.74         140,132,451 
Granted    2,208,000    10.07    6.99      
Forfeited    (103,750)   5.39    4.04      
Exercised    (400,537)   2.52    1.88      
Outstanding, June 30, 2022    13,034,616    6.57         58,809,090 
Exercisable, June 30, 2022    8,562,530    4.11         52,439,132 

 

Schedule Of Share-based Payment Arrangement, Option, Activity
                                
      Weighted         
      average         
   Number of  remaining     Number of  Weighted
Range of exercise prices  outstanding  contractual  Weighted average  vested  average
From  To  options  life (in years)  exercise price  options  exercise price
$0.92    2.96    3,903,762    5.38    2.30    3,868,762    2.29 
$3.15    4.80    2,078,800    5.59    3.30    2,058,800    3.28 
$5.04    8.98    3,957,054    6.32    6.28    2,356,221    6.30 
$10.09    17.03    1,798,000    9.38    11.05    209,997    14.40 
$18.11    24.58    1,297,000    9.08    19.39    68,750    24.03 
           13,034,616              8,562,530     
Schedule of general and administrative expenses and research and development expenses
                    
   Three months ended June 30,  Nine months ended June 30,
   2022  2021  2022  2021
General and administrative  $1,490,267   $1,048,606   $4,739,021   $2,265,387 
Research and development   2,498,347    1,245,319    7,597,823    2,814,008 
Total stock-based compensation  $3,988,614   $2,293,925   $12,336,844   $5,079,395 
Schedule of weighted average assumptions for fair value of each option award
          
   2022  2021
Risk-free interest rate   3.10%   0.71%
Expected life of options (years)   5.51    5.66 
Annualized volatility   84.12%   95.87%
Dividend rate   0.00%   0.00%